BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Treatment
93 results:

  • 1. Gynaecological cancer incidence and mortality trends in a Brazilian State with medium human development index: A 22-year analysis.
    da Silva BEB; de Lemos LMD; Moura AR; Ferrari YAC; Lima MS; Santos MO; Lima CA
    Cancer Epidemiol; 2024 Feb; 88():102493. PubMed ID: 38056244
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Zhao S; Li Y; Xu J; Shen L
    Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Epidemiology of cancers among older adults in India: findings from the National cancer Registry Programme.
    Sankarapillai J; Krishnan S; Ramamoorthy T; Sudarshan KL; Das P; Chaturvedi M; Mathur P
    Public Health; 2023 Oct; 223():230-239. PubMed ID: 37683494
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [treatment and prognosis analysis of 488 patients with FIGO 2018 stage Ⅲc squamous cervical cancer].
    Feng T; Shou HF; Yuan SH; Tang HR; Lyu XJ; Yin ZM; Lou HM; Ni J
    Zhonghua Fu Chan Ke Za Zhi; 2023 May; 58(5):359-367. PubMed ID: 37217343
    [No Abstract]    [Full Text] [Related]  

  • 5. Molecular mechanisms augmenting resistance to current therapies in clinics among cervical cancer patients.
    Das S; Babu A; Medha T; Ramanathan G; Mukherjee AG; Wanjari UR; Murali R; Kannampuzha S; Gopalakrishnan AV; Renu K; Sinha D; George Priya Doss C
    Med Oncol; 2023 Apr; 40(5):149. PubMed ID: 37060468
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Incidence and treatment outcomes of uterine cervical cancer in Korea 1999-2018 from the national cancer registry.
    Suh DH; Ha HI; Lee YJ; Lim J; Won YJ; Lim MC
    J Gynecol Oncol; 2023 Mar; 34(2):e39. PubMed ID: 36731896
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Advanced Ann Arbor stage and age over 60 years as prognostic predictors in patients with primary cervical lymphoma: a retrospective cohort study and systematic review.
    Gao L; Chen X; Zhao J; Xu A; Liu M; Yu H; Kong S; Li S
    BMC Cancer; 2023 Jan; 23(1):95. PubMed ID: 36707772
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Phytochemical Analysis and Profiling of Antitumor Compounds of Leaves and Stems of
    Youssef AMM; Maaty DAM; Al-Saraireh YM
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677687
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Ablation of cervical Lymph Nodes in Patients with Thyroid cancer: A Comparison between Cryoablation and Percutaneous Ethanol Injection.
    Young S; Chen T; Golzarian J; Sanghvi T
    J Vasc Interv Radiol; 2023 May; 34(5):777-781.e1. PubMed ID: 36521788
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Analysis of the disease burden trend of malignant tumors of the female reproductive system in China from 2006 to 2020.
    Han X; Wang Z; Huang D; Deng K; Wang Q; Li C; Zhu J
    BMC Womens Health; 2022 Dec; 22(1):504. PubMed ID: 36476597
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinical Outcome and Risk Factors of Chronic Radiation Proctitis Following Pelvic Radiation Therapy.
    Im CM; Cho IJ; Yu HJ; Han B; Oh HH; Seo YJ; Kim KH; Myung DS; Cho SB; Lee WS; Nam TK; Joo YE
    Anticancer Res; 2022 Dec; 42(12):5951-5959. PubMed ID: 36456158
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Current Progress and Perspectives of CDC20 in Female Reproductive cancers.
    Ni K; Hong L
    Curr Mol Med; 2023; 23(3):193-199. PubMed ID: 35319365
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Driver gene mutations in micro-invasive cervical squamous cancers have no prognostic significance.
    Kashofer K; Regauer S; Reich O; Petru E; Winter E
    Gynecol Oncol; 2022 Apr; 165(1):121-128. PubMed ID: 35101299
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The prevalence of human papillomavirus and bacterial vaginosis among young women in China: a cross-sectional study.
    Lin W; Zhang Q; Chen Y; Chen L; Dong B; Sun P
    BMC Womens Health; 2021 Dec; 21(1):409. PubMed ID: 34886845
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Tumoral Morphologic Features From cervical Biopsies That Are Predictive of a Negligible Risk for Nodal Metastasis and Tumor Recurrence in Usual-type cervical Adenocarcinomas: A Multi-institutional Study.
    Wang Y; Chang RJ; Luo RZ; Yu J; Zhang X; Yang X; Quddus MR; Li L; Yang W; Liu A; Jiang Q; Zhao R; Zhu H; Zhou F; Wang Y; Sheng X; Liu LL; Wen YL; Banet N; Sung CJ; Qi Y; Bi R; Li M; Wang Y; Li J; Lin W; Wang Y; Rivera G; Chen H; Holloway SB; Fadare O; Liu J; Wang J; Lea J; Kong B; Zheng W
    Am J Surg Pathol; 2022 May; 46(5):713-724. PubMed ID: 34753864
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Radical Surgery After Neoadjuvant Chemotherapy for Locally Advanced Neuroendocrine cancer of the Cervix.
    Caruso G; Palaia I; DI Donato V; Pernazza A; Gallo R; Perniola G; Leopizzi M; Della Rocca C; Muzii L; Panici PB
    Anticancer Res; 2021 Sep; 41(9):4431-4438. PubMed ID: 34475065
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A Case Series of Radiation-induced Hemorrhagic Gastroduodenitis.
    Kojima Y; Takeuchi T; Nishida S; Iwatsubo T; Kawaguchi S; Harada S; Ota K; Akutagawa H; Higuchi K
    Intern Med; 2021; 60(16):2529-2535. PubMed ID: 34393154
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Translation and validation of the Chinese version of the MD Anderson symptom inventory for measuring perioperative symptom burden in patients with gynecologic cancer.
    Zhang T; Zheng YY; Yang ZR; Shi Q; Wang XS; Zhao J; Yang M; Wu CL; Wang GR
    BMC Womens Health; 2021 Jul; 21(1):276. PubMed ID: 34325677
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Trends in cervical cancer mortality in China from 1989 to 2018: an age-period-cohort study and Joinpoint analysis.
    Guo M; Xu J; Du J
    BMC Public Health; 2021 Jul; 21(1):1329. PubMed ID: 34229639
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Recommendations from the European Commission Initiative on Breast cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative.
    Giorgi Rossi P; Lebeau A; Canelo-Aybar C; Saz-Parkinson Z; Quinn C; Langendam M; Mcgarrigle H; Warman S; Rigau D; Alonso-Coello P; Broeders M; Graewingholt A; Posso M; Duffy S; Schünemann HJ;
    Br J Cancer; 2021 Apr; 124(9):1503-1512. PubMed ID: 33597715
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.